Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome)

Nephrology Dialysis Transplantation - Tập 15 Số 7 - Trang 953-960 - 2000
Peter Stenvinkel1,2,3,4, Olof Heimbürger, Bengt Lindholm1,2,3,4, George A. Kaysen1,2,3,4, Jonas Bergström1,2,3,4
12Division of Nephrology, Department of Medicine, University of California,
2Davis and 3Department of Veterans Affairs Medical Center, Mather, CA, USA
3Department of Renal Medicine K56, Huddinge University Hospital, S-141 86 Huddinge, Sweden.
4Divisions of Renal Medicine and 1Baxter Novum, Department of Clinical Science and Karolinska Institutet, Huddinge University Hospital, Stockholm, Sweden

Tóm tắt

Từ khóa


Tài liệu tham khảo

Marckmann P. Nutritional status of patients on hemodialysis and peritoneal dialysis. Clin Nephrol1988; 29: 75–78

Bergström J, Lindholm B. Nutrition and adequacy of dialysis. How do hemodialysis and CAPD compare? Kidney Int1993; 34: S39

Cianciaruso B, Brunori G, Kopple JD et al. Cross‐sectional comparison of malnutrition in continuous ambulatory dialysis and hemodialysis patients. Am J Kidney Dis1995; 26: 475–483

Qureshi AR, Alvestrand A, Danielsson A, Divino‐Filho JC, Gutierrez A, Lindholm B et al. Factors influencing malnutrition in hemodialysis patients. A cross‐sectional study. Kidney Int1998; 53: 773–782

Simons JP, Scols AM, Buurman WA, Wouters EF. Weight loss and low body cell mass in males with lung cancer: relationship with systemic inflammation, acute‐phase response, resting energy expenditure, and catabolic and anabolic hormones. Clin Sci1999; 97: 215–223

Munro R, Capell H. Prevalence of low body mass in rheumatoid arthritis: associations with the acute phase response. Ann Rheum Dis1997; 56: 326–329

Stenvinkel P, Heimbürger O, Paultre F et al. Strong associations between malnutrition, inflammation and atherosclerosis in chronic renal failure. Kidney Int1999; 55: 1899–1911

Heimbürger O, Qureshi AR, Blaner WS, Berglund L, Stenvinkel P. Hand‐grip muscle strength, lean body mass and plasma proteins as markers of nutritional status in patients with chronic renal failure close to start of dialysis therapy. Am J Kidney Dis2000; in press

Johanson A, Samuelsson O, Haraldson B, Bosaeus J, Attman P‐O. Body composition in patients treated with peritoneal dialysis. Nephrol Dial Transplant1998; 13: 1511–1517

Hakim RM, Levin N. Malnutrition in hemodialysis patients. Am J Kidney Dis1993; 21: 125–137

Kopple JD. Dietary protein and energy requirements in ESRD patients. Am J Kidney Dis1998; 32[Suppl. 4]: S97–S104

Monteon FJ, Laidlaw SA, Shaib JK, Kopple JD. Energy expenditure in patients with chronic renal failure. Kidney Int1986; 30: 741–747

Schneeweiss B, Graninger W, Stockenhuher F et al. Energy metabolism in acute and chronic renal failure. Am J Clin Nutr1990; 52: 596–601

Ikizler TA, Wingard RL, Sun M, Harvell J, Parker RA, Hakim RM. Increased energy expenditure in hemodialysis patients. J Am Soc Nephrol1996; 7: 2646–2653

Bergström J, Fürst P, Alvestrand A, Lindholm B. Protein and energy intake, nitrogen balance and nitrogen losses in patients treated with continuous ambulatory peritoneal dialysis. Kidney Int1993; 44: 1048–1057

Lowrie EG, Lew NL. Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis1990; 15: 458–482

Avram MM, Fein PA, Bonomini L et al. Predictors of survival in continuous ambulatory peritoneal dialysis patients: a five year prospective study. Peritoneal Dial Int1996; 16 [Suppl. 1]: S190–S194

Avram MM, Goldwasser P, Erroa M, Fein PA. Predictors of survival in continuous ambulatory peritoneal dialysis patients: the importance of prealbumin and other nutritional and metabolic parameters. Am J Kidney Dis1994; 23: 91–98

Folsom AR, Ma J, Eckfeldt JH, Nieto FJ, Metcalfe PA, Barnes RW. Low serum albumin. Association with diabetes mellitus and other cardiovascular risk factors but not with prevalent cardiovascular disease or carotid artery intima media–media thickness. Ann Epidemiol1995; 5: 186–191

Koch M, Kutkuhn B, Grabensee B, Ritz E. Apolipoprotein A, fibrinogen, age, and a history of stroke are predictors of death in dialyzed diabetic patients: a prospective study in 412 subjects. Nephrol Dial Transplant1997; 12: 2603–2611

Struijk DG, Krediet RT, Koomen GCM, Boeschoten EW, Arisz L. The effect of serum albumin at the start of continuous ambulatory peritoneal dialysis treatment on patient survival. Peritoneal Dial Int1994; 14: 121–126

Acchiardo SR, Moore LW, Latour PA. Malnutrition as a main factor in morbidity and mortality of hemodialysis patients. Kidney Int1983; 24 [Suppl. 16]: S199–S203

Kaysen GA. Biological basis of hypoalbuminemia in ESRD. Kidney Int1998; 9: 2368–2376

Smith G, Robinson PH, Fleck A. Serum albumin distribution in early treated anorexia nervosa. Nutrition1996; 12: 677–684

Keys A, Brozek J, Henschel A, Mickelsen O, Taylor HL. The biology of human starvation. The University of Minnesota Press, Minneapolis, 1950

Schoenfeld PY. Albumin is an unreliable marker of nutritional status. Semin Dial1992; 5: 218–223

Heimbürger O, Bergström J, Lindholm B. Is serum albumin an indication of nutritional status in CAPD patients? Peritoneal Dial Int1994; 14: 108–114

Kaysen GA, Schonfeld PY. Albumin homeostasis in patients undergoing continuous ambulatory peritoneal dialysis. Kidney Int1984; 25: 107–114

Kaplan AA, Halley SE, Lapkin RA, Graeber CW. Dialysate protein losses with bleach processed polysulphone dialyzers. Kidney Int1995; 47: 573–578

Moshage HJ, Janssen JAM, Franssen JH, Hafkenscheid JCM, Yap SH. Study of the molecular mechanisms of decreased liver synthesis of albumin in inflammation. J Clin Invest1987; 79: 1635–1641

Kaysen GA, Stevenson FT, Depner TA. Determinants of albumin concentration in hemodialysis patients. Am J Kidney Dis1997; 29: 658–668

Yeun JY, Kaysen GA. Acute phase proteins and peritoneal dialysate albumin loss are the main determinants of serum albumin and peritoneal dialysis patients. Am J Kidney Dis1997; 30: 923–927

Bergström J, Heimbürger O, Lindholm B, Qureshi AR. Elevated serum C‐reactive protein is a strong predictor of increased mortality and low serum albumin in hemodialysis (HD) patients. J Am Soc Nephrol1995; 6: 573–

Bologa RM, Levine DM, Parker TS et al. Interleukin‐6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients. Am J Kidney Dis1998; 32: 107–114

Ridker PM, Cushman M, Stampfer MJ, Russell PT, Hennekens CH. Inflammation, aspirin and the risk of cardiovascular disease in apparently healthy men. N Engl J Med1997; 336: 973–979

Muir KW, Weir CJ, Alwan W, Squire IB, Lees KR. C‐reactive protein and outcome after ischemic stroke. Stroke1999; 30: 981–985

Harris TB, Ferrucci L, Tracy RP et al. Association of elevated interleukin‐6 and C‐reactive protein levels with mortality in the elderly. Am J Med1999; 106: 506–512

Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int1999; 55: 648–658

Iseki K, Tozawa M, Yoshi S, Fukiyama K. Serum C‐reactive (CRP) and risk of death in chronic dialysis patients. Nephrol Dial Transplant1999; 14: 1956–1960

Ikizler TA, Wingard RL, Harvell J, Shyr Y, Hakim RM. Association of morbidity with markers of nutrition and inflammation in chronic hemodialysis patients: a prospective study. Kidney Int1999; 55: 1945–1951

Owen WF, Lowrie EG. C‐reactive protein as an outcome predictor for maintenance hemodialysis patients. Kidney Int1998; 54: 627–636

Pereira BJG, Shapiro L, King AJ, Falagas ME, Strom JA, Dinarello CA. Plasma levels of IL‐1β, TNF‐α and their specific inhibitors in undialyzed chronic renal failure, CAPD and hemodialysis patients. Kidney Int1994; 45: 890–896

Kimmel PL, Phillips TM, Simmens SJ et al. Immunologic function and survival in hemodialysis patients. Kidney Int1998; 54: 236–244

Bistrian BR, Schwartz J, Istfan NW. Cytokines, muscle proteolysis, and the catabolic response to infection and inflammation. Proc Soc Exp Biol Med1992; 200: 220–223

Plata‐Salamán CR. Cytokines and anorexia: a brief overview. Semin Oncol1998; 25: 64–72

Nawabi MD, Block KP, Chakrabarti MC, Buse MG. Administration of endotoxin, tumour necrosis factor, or interleukin‐1 to rats activates skeletal muscle branched‐chain alpha‐keto acid dehydrogenase. J Clin Invest1990; 85: 256–263

Schneeweiss B, Druml W, Graninger W et al. Energy metabolism in patients with severe heart failure. Wien Klin Wochenschr1987; 99: 710–712

Falconer JS, Fearon KCH, Plesler CE, Ross JA, Carter DC. Cytokines, the resting acute‐phase response, and resting energy expenditure in cachectic patients with pancreatic cancer. Ann Surg1994; 219: 325–331

Staal‐van den Brekel AJ, Dentener MA, Schols AM, Buurman WA, Wouters EF. Increased resting energy expenditure and weight loss are related to a systemic inflammatory response in lung cancer patients. J Clin Oncol1995; 13: 2600–2605

Roubenhoff R, Roubenhoff RA, Cannon JG et al. Rheumatoid cachexia: cytokine‐driven hypermetabolism accompanying reduced body cell mass in chronic inflammation. J Clin Invest1994; 93: 2379–2386

Heijligenberg R, Romijn JA, Westerterp KR, Jonkers CF, Prins JM, Sauerwein HP. Total energy expenditure in human immunodeficiency virus‐infected men and healthy controls. Metab Clin Exp1997; 46: 1324–1326

Harty J, Conway L, Keegan M et al. Energy metabolism during CAPD; a controlled study. Adv Peritoneal Dial1995; 11: 229–233

Campillo B, Bories PN, Devanlay M et al. Aging, energy expenditure and nutritional status: evidence for denutrition‐related hypermetabolism. Ann Nutr Metab1992; 36: 265–272

Maggi E, Bellazzi R, Falaschi F et al. Enhanced LDL oxidation in uremic patients: an additional mechanism for accelerated atherosclerosis. Kidney Int1994; 45: 876–883

Stenvinkel P, Holmberg I, Heimbürger O, Diczfalusy U. A study of plasmalogen as an index of oxidative stress in patients with chronic renal failure. Evidence of increased oxidative stress in malnourished patients. Nephrol Dial Transplant1998; 13: 2594–2600

Sguyen‐Choa T, Massy ZA, DeBandt JP et al. Factors influencing oxidative stress in hemodialysis (HD) patients. J Am Soc Nephrol1999; 10: 296–

Witko‐Sarsat V, Friedlander M, Khoa TN et al. Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunol1998; 161: 2524–2532

Cha MK, Kim IH. Glutahthione‐linked thiol peroxidase activity of human serum albumin: a possible antioxidant role of serum albumin in blood plasma. Biochem Biophys Res Commun1996; 222: 619–625

Soejima A, Matsuzawa N, Miyake N et al. Hypoalbuminemia accelerates erythrocyte membrane lipid peroxidation in chronic hemodialysis patients. Clin Nephrol1999; 51: 92–97

Kanani PM, Sinkey CA, Browning RL, Allaman M, Knapp HR, Haynes WG. Role of oxidant stress in endothelial dysfunction produced by experimental hyperhomocysteinemia in humans. Circulation1999; 100: 1161–1168

Werver R, Boer P, Hijmering M et al. Nitric oxide production is reduced in patients with chronic renal failure. Arterioscler Thromb Vasc Biol1999; 19: 1168–1172

Matsumoto A, Hirata Y, Kakoki M et al. Increased excretion of nitric oxide in exhaled air of patients with chronic renal failure. Clin Sci1999; 96: 67–74

van Guldener C, Janssen MJ, Lambert J, Steyn M, Donker AJ, Steuhower CC. Endothelium‐dependent vasodilation is impaired in peritoneal dialysis patients. Nephrol Dial Transplant1998; 13: 1782–1786

Hand MF, Haynes WG, Webb DJ. Hemodialysis and l‐arginine, but not d‐arginine, correct renal‐failure associated endothelial dysfunction. Kidney Int1998; 53: 1068–1077

Keaney JF, Simon DI, Stamler JS et al. NO forms an adduct with serum albumin that has endothelium‐derived relaxing factor‐like properties. J Clin Invest1993; 91: 1582–1589

Kim SB, Chi HS, Park JS, Hong CD, Yang WS. Effect of increasing serum albumin on plasma d‐dimer, von Willebrand factor, and platelet aggregation in CAPD patients. Am J Kidney Dis1999; 33: 312–317

Kessler P, Popp R, Busse R, Schini‐Kerth VB. Proinflammatory mediators chronically downregulate the formation of the endothelium‐derived hyperpolarizing factor in arteries via a nitric oxide/cyclic GMP‐dependent mechanism. Circulation1999; 99: 1878–1884

Schalkwijk CG, Poland DC, van Dijk W et al. Plasma concentrations of C‐reactive protein is increased in type 1 diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction: evidence for chronic inflammation. Diabetologia1999; 42: 351–357

Carr JG, Stevensson LW, Walden JA, Heber D. Prevalence and hemodynamic correlates of malnutrition in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol1989; 63: 709–713

Mancini DM, Walter G, Reicek N et al. Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure. Circulation1992; 85: 1364–1373

Volterrani M, Clark AL, Ludman PF et al. Determinants of exercise capacity in chronic heart failure. Eur Heart J1994; 15: 801–809

Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med1990; 323: 236–241

Munger MA, Johnsson B, Amber IJ, Callahan KS, Bilbert EM. Circulating concentrations of proinflammatory cytokines in mild or moderate heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol1996; 77: 723–727

Anker SD, Ponikowski P, Varney S et al. Wasting as independent risk factor for mortality in chronic heart failure. Lancet1997; 349: 1050–1053

Parfrey PS, Foley RN, Harnett JD, Kent GM, Murray DC, Barre PE. Outcome and risk factors for left ventricular disorders in chronic uraemia. Nephrol Dial Transplant1996; 11: 1277–1285

Bergström J, Lindholm B. Malnutrition, cardiac disease and mortality—an integrated point of view. Am J Kidney Dis1998; 32: 834–841

EDTA/ERA Registry Report. Demography of dialysis and transplantation in Europe 1984. Nephrol Dial Transplant1986; 1: 1–8

Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal failure. Am J Kidney Dis1998; 32 [Suppl. 5]: S112–S119

Stenvinkel P, Heimbürger O, Wang T, Elinder C‐G, Bergström J, Lindholm B. A syndrome of malnutrition, inflammation and atherosclerosis (MIA) is associated with elevated serum hyaluronan and increased mortality in chronic renal failure (CRF). J Am Soc Nephrol1999; 10: 182A

Keane WF, Collins AJ. Influence of co‐morbidity on mortality and morbidity of hemodialysis patients. Am J Kidney Dis1994; 24: 1010–1018

Baltzan MA, Shoker AS. Malnutrition and dialysis (letter). Kidney Int1998; 53: 999

Kopple JD, Chumlea WC, Gassman JJ, et al. Relationship between GFR and nutritional status—results from the MDRD study. J Am Soc Nephrol1994; 5: 335

Ikizler TA, Greene JH, Wingard RL, Parker RA, Hakim RM. Spontaneous dietary intake during progression of chronic renal failure. Kidney Int1995; 6: 1386–1391

Foulks CJ. An evidence‐based evaluation of intradialytic parenteral nutrition. Am J Kidney Dis1999; 33: 186–192

Davies SJ, Phillips L, Griffiths AM, Naish PF, Russell GI. An analysis of the effects of increasing delivered dialysis treatment to malnourished peritoneal dialysis patients. Kidney Int2000; 57: 1743–1754

Ericsson F, Divino JD, Lindgren B. Low grade inflammatory activity abolishes the anabolic effect of growth hormone (GH) on metabolism in hemodialysis patients. J Am Soc Nephrol1999; 10: 162A

Beddhu S, Zeidel S, Stark S, Saul M, Bruns F. Comorbidity influences the impact of albumin (Alb) on dialysis outcomes. J Am Soc Nephrol1999; 10: 234A

The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med1992; 327: 685–691

CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the north Scandinavian enalapril survival study. N Engl J Med1987; 316: 1429–1435

Stenvinkel P, Andersson P, Wang T et al. Do ACE‐inhibitors suppress tumor necrosis factor‐α production in advanced chronic renal failure? J Intern Med1999; 246: 503–507

Anker SD, Negassa A, Coats AJ, Poole‐Wilson PA, Yusuf S. Weight loss in chronic heart failure (CHF) and the impact of treatment with ACE inhibitors. Results from the SOLVD treatment trial. Circulation1999; 100: 1781

Solzbach U, Hornig B, Jeserich M, Just H. Vitamin C improves endothelial dysfunction of epicardial coronary arteries in hypertensive patients. Circulation1997; 96: 1513–1519

Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: is there a link? Lancet1997; 350: 430–436

Elliot MJ, Maini RN, Feldmann M et al. Randomised double‐blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis. Lancet1994; 344: 1105–1110

Reyes‐Terán G, Sierra‐Madero JG, Martínez del Cerro V et al. Effects of thalidomide on HIV‐associated wasting syndrome: a randomized, double blind, placebo‐controlled clinical study. AIDS1996; 10: 1501–1507

Tramontana JM, Utaipat U, Molloy A, Akarasewi P, Burroughs M, Makonkawkeyoon S et al. Thalidomide treatment reduces tumour necrosis factor‐α production and enhances weight gain in patients with pulmonary tuberculosis. Mol Med1995; 1: 384–397